Alexy Tamas, Pais Eszter, Meiselman Herbert J
Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Rev Sci Instrum. 2009 Sep;80(9):096102. doi: 10.1063/1.3212564.
The erythrocyte sedimentation rate (ESR) is a nonspecific but simple and inexpensive test that was introduced into medical practice in 1897. Although it is commonly utilized in the diagnosis and follow-up of various clinical conditions, ESR has several limitations including the required 60 min settling time for the test. Herein we introduce a novel use for a commercially available computerized tube viscometer that allows the accurate prediction of human Westergren ESR rates in as little as 4 min. Owing to an initial pressure gradient, blood moves between two vertical tubes through a horizontal small-bore tube and the top of the red blood cell (RBC) column in each vertical tube is monitored continuously with an accuracy of 0.083 mm. Using data from the final minute of a blood viscosity measurement, a sedimentation index (SI) was calculated and correlated with results from the conventional Westergren ESR test. To date, samples from 119 human subjects have been studied and our results indicate a strong correlation between SI and ESR values (R(2)=0.92). In addition, we found a close association between SI and RBC aggregation indices as determined by an automated RBC aggregometer (R(2)=0.71). Determining SI on human blood is rapid, requires no special training and has minimal biohazard risk, thus allowing physicians to rapidly screen for individuals with elevated ESR and to monitor therapeutic responses.
红细胞沉降率(ESR)是一项非特异性但简单且成本低廉的检测方法,于1897年被引入医学实践。尽管它常用于各种临床病症的诊断和随访,但ESR有几个局限性,包括检测所需的60分钟沉降时间。在此,我们介绍一种商用计算机化管粘度计的新用途,它能够在短短4分钟内准确预测人体魏氏ESR率。由于初始压力梯度,血液通过水平小孔径管在两根垂直管之间流动,并且每根垂直管中红细胞(RBC)柱的顶部以0.083毫米的精度被连续监测。利用血液粘度测量最后一分钟的数据,计算出沉降指数(SI),并将其与传统魏氏ESR检测结果相关联。迄今为止,已经对119名人类受试者的样本进行了研究,我们的结果表明SI与ESR值之间存在很强的相关性(R² = 0.92)。此外,我们发现SI与通过自动红细胞聚集仪测定的红细胞聚集指数之间存在密切关联(R² = 0.71)。测定人体血液中的SI快速、无需特殊培训且生物危害风险极小,从而使医生能够快速筛查ESR升高的个体并监测治疗反应。